Yoshihiro Hayakawa

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Venues

Cancer science

International journal of molecular sciences

Journal of natural medicines

Cells

Univesity of Toyama

Toyama Medical and Pharmaceutical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Univesity of Toyama

Japan

Professor :: Institute of Natural Medicine

University of Toyama

Japan

Associate Professor :: Institute of Natural Medicine

University of Tokyo

Japan

Associate Professor :: Graduate School of Pharmaceutical Sciences

Merck Research Laboratories Tsukuba

Japan

Research Fellow/Group Leader :: Pharmacology

Peter MacCallum Cancer Centre

Australia

Senior Research Officer :: Cancer Immunology Program

Toyama Medical and Pharmaceutical University

Japan

Postdoc :: Institute of Natural Medicine

Education History

Toyama Medical and Pharmaceutical University

Japan

PHD :: Graduate School of Pharmaceutical Sciences

Toyama Medical and Pharmaceutical University

Japan

MSC :: Graduate School of Pharmaceutical Sciences

Publications

Sisca Ucche, Yoshihiro Hayakawa
Immunological Aspects of Cancer Cell Metabolism. International journal of molecular sciences 25 (10) (2024)
Sisca Ucche, Yoshihiro Hayakawa
Immunological Aspects of Cancer Cell Metabolism. International journal of molecular sciences 25 (10) (2024)
Shohei Kikuchi, Akinori Wada, Yusuke Kamihara, Kosuke Okazaki, Paras Jawaid, Mati Ur Rehman, Eiji Kobayashi, Takeshi Susukida, Tomoki Minemura, Yoshimi Nabe, Noriaki Iwao, Tatsuhiko Ozawa, Ryo Hatano, Mitsugu Yamada, Hiroyuki Kishi, Yuji Matsuya, Mineyuki Mizuguchi, Yoshihiro Hayakawa, Nam H Dang, Yasumitsu Sakamoto, Chikao Morimoto, Tsutomu Sato
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies. Cells 12 (7) (2023)
Nguyen Tien Dung, Takeshi Susukida, Sisca Ucche, Ka He, So-Ichiro Sasaki, Ryuji Hayashi, Yoshihiro Hayakawa
Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model. Nutrients 15 (16) (2023)
Eiji Kobayashi, Yusuke Kamihara, Miho Arai, Akinori Wada, Shohei Kikuchi, Ryo Hatano, Noriaki Iwao, Takeshi Susukida, Tatsuhiko Ozawa, Yuichi Adachi, Hiroyuki Kishi, Nam H Dang, Taketo Yamada, Yoshihiro Hayakawa, Chikao Morimoto, Tsutomu Sato
Development of a Novel CD26-Targeted Chimeric Antigen Receptor T-Cell Therapy for CD26-Expressing T-Cell Malignancies. Cells 12 (16) (2023)
Sisca Ucche, Satoru Yokoyama, Marija Mojic, Kohei Oki, Chikako Ohshima, Haruka Tsuihiji, Ichiro Takasaki, Hideaki Tahara, Yoshihiro Hayakawa
GSTA4 governs melanoma immune resistance and metastasis. Molecular cancer research : MCR (2022)
Tatsuhiko Ozawa, Hideki Tani, Yuki Anraku, Shunsuke Kita, Emiko Igarashi, Yumiko Saga, Noriko Inasaki, Hitoshi Kawasuji, Hiroshi Yamada, So-Ichiro Sasaki, Mayu Somekawa, Jiei Sasaki, Yoshihiro Hayakawa, Yoshihiro Yamamoto, Yoshitomo Morinaga, Nobuyuki Kurosawa, Masaharu Isobe, Hideo Fukuhara, Katsumi Maenaka, Takao Hashiguchi, Hiroyuki Kishi, Isao Kitajima, Shigeru Saito, Hideki Niimi
Novel super-neutralizing antibody UT28K is capable of protecting against infection from a wide variety of SARS-CoV-2 variants. mAbs 14 (1) (2022)
Subehan Lallo, Besse Hardianti, Sartini Sartini, Ismail Ismail, Dewi Laela, Yoshihiro Hayakawa
Ethyl P-Methoxycinnamate: An Active Anti-Metastasis Agent and Chemosensitizer Targeting NFκB from Kaempferia galanga for Melanoma Cells. Life (Basel, Switzerland) 12 (3) (2022)
Wen-Yong Gao, Chantana Boonyarat, Pitchayakarn Takomthong, Kusawadee Plekratoke, Yoshihiro Hayakawa, Chavi Yenjai, Rawiwun Kaewamatawong, Suchada Chaiwiwatrakul, Pornthip Waiwut
Acridone Derivatives from Atalantia monophyla Inhibited Cancer Cell Proliferation through ERK Pathway. Molecules (Basel, Switzerland) 27 (12) (2022)
Tomoko Nakamura, Eiji Kobayashi, Hiroshi Hamana, Yoshihiro Hayakawa, Atsushi Muraguchi, Atsushi Hayashi, Tatsuhiko Ozawa, Hiroyuki Kishi
Evaluation of chimeric antigen receptor of humanized rabbit-derived T cell receptor-like antibody. Cancer science 113 (10) (2022)
Makoto Fujimoto, Miki Kamiyama, Kosuke Fuse, Hiroki Ryuno, Takeru Odawara, Natsuki Furukawa, Yasuhiro Yoshimatsu, Tetsuro Watabe, Michaela Prchal-Murphy, Veronika Sexl, Hideaki Tahara, Yoshihiro Hayakawa, Takehiro Sato, Kohsuke Takeda, Isao Naguro, Hidenori Ichijo
ASK1 suppresses NK cell-mediated intravascular tumor cell clearance in lung metastasis. Cancer science 112 (4) (2021)
Satoru Yokoyama, Atsushi Takahashi, Ryota Kikuchi, Soshi Nishibu, Jennifer A Lo, Miroslav Hejna, Wooyoung M Moon, Shinichiro Kato, Yue Zhou, F Stephen Hodi, Jun S Song, Hiroaki Sakurai, David E Fisher, Yoshihiro Hayakawa
SOX10 regulates melanoma immunogenicity through an IRF4-IRF1 axis. Cancer research (2021)
Lin Umeyama, Besse Hardianti, Shiori Kasahara, Dya Fita Dibwe, Suresh Awale, Satoru Yokoyama, Yoshihiro Hayakawa
Anti-inflammatory effects of Morus alba Linne bark on the activation of toll-like receptors and imiquimod-induced ear edema in mice. BMC complementary medicine and therapies 21 (1) (2021)
Min-Kyoung Shin, Fumito Sasaki, Dae-Won Ki, Nwet Nwet Win, Hiroyuki Morita, Yoshihiro Hayakawa
Anti-metastatic effects of ergosterol peroxide from the entomopathogenic fungus Ophiocordyceps gracilioides on 4T1 breast cancer cells. Journal of natural medicines 75 (4) (2021)
So-Ichiro Sasaki, Di Zhang, Sadahiro Iwabuchi, Yamato Tanabe, Shinichi Hashimoto, Akira Yamauchi, Katsuhiro Hayashi, Hiroyuki Tsuchiya, Yoshihiro Hayakawa, Tomohisa Baba, Naofumi Mukaida
Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation. Cancer science 112 (12) (2021)
Marija Mojic, Kiyomi Shitaoka, Chikako Ohshima, Sisca Ucche, Fulian Lyu, Hiroshi Hamana, Hideaki Tahara, Hiroyuki Kishi, Yoshihiro Hayakawa
NKG2D defines tumor-reacting effector CD8+ T cells within tumor microenvironment. Cancer science 112 (9) (2021)
Amira A Abdellatef, Moustafa Fathy, Abd El-Salam I Mohammed, Marwa S Abu Bakr, Amal H Ahmed, Hatem S Abbass, Ahmed H El-Desoky, Hiroyuki Morita, Toshio Nikaido, Yoshihiro Hayakawa
Inhibition of cell-intrinsic NF-κB activity and metastatic abilities of breast cancer by aloe-emodin and emodic-acid isolated from Asphodelus microcarpus. Journal of natural medicines 75 (4) (2021)
Kiho Miyazato, Hideaki Tahara, Yoshihiro Hayakawa
Antimetastatic effects of thalidomide by inducing the functional maturation of peripheral natural killer cells. Cancer science 111 (8) (2020)
Kiho Miyazato, Yoshihiro Hayakawa
Pharmacological targeting of natural killer cells for cancer immunotherapy. Cancer science 111 (6) (2020)
Yutaka Yamamoto, Kiho Miyazato, Kei Takahashi, Naoki Yoshimura, Hideaki Tahara, Yoshihiro Hayakawa
Lung-resident natural killer cells control pulmonary tumor growth in mice. Cancer science 109 (9) (2018)
Marija Mojic, Kazuyoshi Takeda, Yoshihiro Hayakawa
The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion. International journal of molecular sciences 19 (1) (2017)

Yoshihiro Hayakawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshihiro Hayakawa